Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 USD | -0.33% | -7.43% | -.--% |
May. 21 | Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer | CI |
May. 14 | Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 321M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -87M | EV / Sales 2024 * | - |
Net cash position 2024 * | 350M | Net cash position 2025 * | 277M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.84
x | P/E ratio 2025 * |
-3.72
x | Employees | 67 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.89% |
1 day | -0.33% | ||
1 week | -7.43% | ||
1 month | -22.89% | ||
3 months | -22.34% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 11.96 | -0.33% | 63,668 |
24-05-30 | 12 | -4.38% | 62,993 |
24-05-29 | 12.55 | +2.20% | 47,699 |
24-05-28 | 12.28 | -4.95% | 136,649 |
24-05-24 | 12.92 | +9.86% | 98,307 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 321M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ANRO Stock